Dergiler / Turkish Journal of Pediatrics / 2016 / Cilt: 58 - Sayı: 3

A late-diagnosed phenylketonuria case presenting with autism spectrum disorder in early childhood

Sayfa
318–322
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Clinicians should keep in mindthe possibility of treatable disorders in children with autism even when suchdisorders appear unlikely.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:SUMMARY: Mazlum B, Anlar B, Kalkanoğlu-Sivri HS, Karlı-Oğuz K, Özusta Ş,Ünal F.
📊
Temel Bulgular & Veri:Turk J Pediatr 2016; 58: 318-322.Phenylketonuria is one of the most prevalent autosomal recessive hereditarydisorders in Turkey.
💡
Sonuç & Katkı:Clinicians should keep in mindthe possibility of treatable disorders in children with autism even when suchdisorders appear unlikely.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

SUMMARY: Mazlum B, Anlar B, Kalkanoğlu-Sivri HS, Karlı-Oğuz K, Özusta Ş,Ünal F. A late-diagnosed case presenting with autism spectrum disorder inearly childhood. Turk J Pediatr 2016; 58: 318-322.Phenylketonuria is one of the most prevalent autosomal recessive hereditarydisorders in Turkey. If untreated, it results in severe brain damage and canalso be associated with autism in certain patients. We present a three-year oldboy who exhibited the symptoms of autism and was subsequently diagnosedwith phenylketonuria. This case illustrates that because the majority ofautism cases are idiopathic, an occasional patient with a metabolic disordermight be overlooked especially in the era of newborn screening. We alsodiscuss the possible pathogenetic processes leading to autistic symptomsin phenylketonuria, and wish to draw attention to the possibility of casesmissed in the screening program because of less than 100% coverage orinsufficient food intake before blood sampling. Clinicians should keep in mindthe possibility of treatable disorders in children with autism even when suchdisorders appear unlikely.

🔖

Bu Makaleye Atıf Yap

MAZLUM, B., ANLAR, B., ÖZUSTA, Ş., KARLI-OĞUZ, K., KALKANOĞLU-SİVRİ, H. S., ÜNAL, F. (2022). A late-diagnosed phenylketonuria case presenting with autism spectrum disorder in early childhood. Turkish Journal of Pediatrics, Cilt: 58 - Sayı: 3, 318–322. https://ajindex.com/articles/613207

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing, 2013
  2. Kim YS, Leventhal BL, Koh YJ, et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry 2011; 168: 904-912
  3. Elsabbagh M, Divan G, Koh YJ, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res 2012; 5: 160-179
  4. Blumberg SJ, Bramlett MD, Kogan MD, Schieve LA, Jones JR, Lu MC. Changes in prevalence of parentreported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012. Natl Health Stat Report 2013: 1-11
  5. Özalp İ, Coşkun T, Tokatlı A, et al. Neonatal PKU screening in Turkey: 7 years experience in a developing country. Screening 1995; 4: 139-147
  6. Page T. Metabolic approaches to the treatment of autism spectrum disorders. J Autism Dev Disord 2000; 30: 463-469
  7. Zecavati N, Spence SJ. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr Neurol Neurosci Rep 2009; 9: 129-136
  8. Baieli S, Pavone L, Meli C, Fiumara A, Coleman M. Autism and phenylketonuria. J Autism Dev Disord 2003; 33: 201-204
  9. American Psyciatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSMIV). Washington, DC: American Psychiatric Association, 1994
  10. Blumenfeld CM, Wallace MJ, Anderson R. Phenylketonuria-the guthrie screening test-a method of quantitation, observations on reliability and suggestions for improvement. Calif Med 1966; 105: 429-434
  11. Yalaz K, Vanli L, Yilmaz E, Tokatli A, Anlar B. Phenylketonuria in peidatric neurology practice: A series of 146 cases. J Child Neurol 2006; 21: 987-990
  12. Lowe TL, Tanaka K, Seashore MR, Young JG, Cohen DJ. Detection of phenylketonuria in autistic and psychotic children. JAMA 1980; 243: 126-128
  13. Anderson PJ, Wood SJ, Francis DE et al. Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities. Dev Med Child Neurol 2004; 46: 230- 238
  14. Atalar MH. Evaluation of white matter abnormalities with diffusion-weighted imaging in a boy with classical phenylketonuria: A case report. Kafkas J Med Sci 2013; 3: 145-148
  15. Christ SE, Moffitt AJ, Peck D. Disruption of prefrontal function and connectivity in individuals with phenylketonuria. Mol Genet Metab 2010; 99 (Suppl 1): S33-S40
  16. Kono K, Okano Y, Nakayama K, et al. Diffusionweighted MR imaging in patients with phenylke